Union Korea Pharm Co., Ltd. (KOSDAQ:080720)

Union Korea Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,974	4,324	6,579	6,012	20,659	1,558
Short-Term Investments	1,300	1,437	602.13	1,513	461.34	1,576
Cash & Short-Term Investments	4,275	5,761	7,181	7,524	21,120	3,134
Cash Growth	-43.62%	-19.77%	-4.57%	-64.37%	573.86%	-51.77%
Accounts Receivable	17,574	20,435	33,520	33,092	26,147	25,245
Other Receivables	1,564	373.03	748.69	631.13	644.7	1,129
Receivables	19,489	20,808	34,269	33,723	26,792	26,374
Inventory	8,799	12,880	7,910	12,731	10,747	13,647
Prepaid Expenses	110.79	152.38	91.99	76.39	69.3	62.05
Other Current Assets	345.2	597.6	230.35	515.5	53.99	827.27
Total Current Assets	33,018	40,198	49,683	54,570	58,782	44,045
Property, Plant & Equipment	28,001	28,659	34,596	44,613	43,787	39,996
Long-Term Investments	1,467	1,534	2,617	2,450	2,454	2,147
Other Intangible Assets	692.36	742.14	1,081	1,539	1,751	2,012
Long-Term Deferred Tax Assets	3,029	3,037	4,973	8,710	10,564	7,104
Other Long-Term Assets	518.23	580.29	1,266	399.86	1,436	1,578
Total Assets	66,755	74,900	94,425	112,523	119,044	97,183
Accounts Payable	6,418	3,407	2,884	3,080	2,697	2,648
Accrued Expenses	2,754	1,457	1,574	1,013	950.45	835.6
Short-Term Debt	19,680	20,488	34,902	33,966	10,500	9,800
Current Portion of Long-Term Debt	3,000	3,000	1,200	-	4,000	-
Current Portion of Leases	319.82	273.55	167.26	127.24	280	478.58
Other Current Liabilities	12,341	35,323	18,282	20,806	24,793	9,264
Total Current Liabilities	44,513	63,949	59,009	58,992	43,220	23,026
Long-Term Debt	-	-	3,000	3,000	21,026	4,871
Long-Term Leases	184.14	230.99	80.13	31.79	61.48	140.49
Other Long-Term Liabilities	20,058	611.17	486.02	608.58	522.72	302.73
Total Liabilities	65,175	66,651	64,101	63,910	65,445	28,814
Common Stock	3,956	3,956	3,955	3,952	3,952	3,952
Additional Paid-In Capital	47,339	47,339	47,324	47,299	47,299	47,299
Retained Earnings	-40,321	-34,933	-13,717	4,654	5,663	16,561
Treasury Stock	-7,309	-7,309	-7,309	-7,309	-4,592	-
Comprehensive Income & Other	-2,086	-804.32	70.88	16.38	18.9	557.53
Total Common Equity	1,580	8,249	30,324	48,612	52,341	68,369
Shareholders' Equity	1,580	8,249	30,324	48,612	53,599	68,369
Total Liabilities & Equity	66,755	74,900	94,425	112,523	119,044	97,183
Total Debt	23,184	23,993	39,349	37,125	35,867	15,290
Net Cash (Debt)	-18,909	-18,232	-32,169	-29,601	-14,747	-12,155
Net Cash Per Share	-2615.52	-2522.31	-4455.02	-4011.66	-1897.72	-1829.35
Filing Date Shares Outstanding	7.23	7.23	7.23	7.22	7.56	7.9
Total Common Shares Outstanding	7.23	7.23	7.23	7.22	7.56	7.9
Working Capital	-11,495	-23,751	-9,327	-4,422	15,562	21,019
Book Value Per Share	218.50	1141.07	4196.34	6732.64	6925.43	8650.23
Tangible Book Value	887.29	7,507	29,243	47,073	50,590	66,357
Tangible Book Value Per Share	122.73	1038.41	4046.81	6519.47	6693.77	8395.61
Land	6,905	6,905	6,905	6,681	6,656	6,449
Buildings	16,751	17,078	19,817	24,223	25,073	21,732
Machinery	878.98	1,234	1,885	3,450	4,732	5,233
Construction In Progress	2,902	2,902	5,382	9,172	5,512	3,786

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.